Hypercholesterolemia and prostate cancer: a hospital-based case–control study
High levels of serum cholesterol have been proposed to increase the risk of prostate cancer but the epidemiologic evidence is limited.
We conducted a hospital-based case–control study in Fargo, ND, USA, to examine the association between hypercholesterolemia and prostate cancer. Cases were men with incident, histologically confirmed prostate cancer. Controls were men without clinical cancer who were seen at the same hospital for an annual physical exam. Demographic and clinical data were abstracted from patients’ medical charts.
From a patient population aged 50 to 74 years old, we obtained data on 312 White cases and 319 White controls. Hypercholesterolemia was defined as total cholesterol greater than 5.17 (mmol/l). Univariate logistic regression showed a significant association between hypercholesterolemia and prostate cancer (odds ratio (OR) = 1.64, 95% confidence interval (CI): 1.19–2.27). This association changed only slightly after adjustment for age, family history of prostate cancer, body mass index, type 2 diabetes, smoking, and multivitamin use (OR = 1.58, 95% CI: 1.11–2.24). A significant association was found between low HDL and prostate cancer (OR = 1.57, 95% CI: 1.04–2.36). High LDL was associated with a 60% increased risk for prostate cancer (OR = 1.60, 95% CI: 1.09–2.34). Compared to never smokers, current smokers had an 84% increased risk for prostate cancer (OR = 1.84, 95% CI: 1.09–3.13).
This study adds to recent evidence that hypercholesterolemia may increase the risk of prostate cancer in white men.
KeywordsProstate cancer Hypercholesterolemia Lipid profiles Epidemiology Statins
- 7.Swyer G (1942) The cholesterol content of normal and enlarged prostates. Cancer Res 2:372–375Google Scholar
- 23.Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 106:3143Google Scholar
- 33.Key TJ, Allen N, Appleby P et al (2004) Fruits and vegetables and prostate cancer: no association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 109(1):119–124. doi:10.1002/ijc.11671 PubMedCrossRefGoogle Scholar
- 40.Centers for Disease Control and Prevention: Behavioral Risk Factor Surveillance System [www.cdc.gov/brfss]
- 45.Singal V, Khurana V, Caldito G, Fort C (2005) Statins and prostate cancer risk: a large case–control study in Veterans. J Clin Oncol 23:107SGoogle Scholar
- 46.Kaplan SA, Meehan AG, Shah A (2006) The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176(4 Pt 1):1524–1527. doi:10.1016/j.juro.2006.06.003 PubMedCrossRefGoogle Scholar
- 48.http://apps.nccd.cdc.gov/brfss/sex.asp?cat=CA&yr=2005&qkey=4392&state=ND. Accessed on 21 May 2007
- 49.http://apps.nccd.cdc.gov/BRFSS/page.asp?cat=XX&yr=2007&state= ND#XX. Accessed on 11 May 2008
- 51.Moorjani S, Dupont A, Labrie F et al (1988) Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. J Clin Endocrinol Metab 66(2):314–322PubMedCrossRefGoogle Scholar